Get the information you need today and plan for a better tomorrow.
ALZ-1 is a simple blood test that detects one of the newly identified risk factors for Alzheimer’s disease, years before symptoms develop.
Excess amounts of Non-Ceruloplasmin Copper (also known as Non-Cp Copper or free copper), bind to micronutrients that then travel across the brain barrier. Small changes in the brain begin, long before the first signs of memory loss, eventually becoming severe enough to interfere with daily life.
With proper treatment, high-levels of Non-Cp Copper may be corrected. Lifestyle changes that you make now, may save you and your loved ones, the heartbreak of Alzheimer’s disease.
Take charge and avoid becoming one of the 46.7 million people worldwide whose lives are ravaged by this horrible illness.
Early Detection is Critical. The ALZ-1 Test is the tool you need to take steps now to prevent or delay the onset of Alzheimer’s disease in the future.
The ALZ-1 Test
Research has proven that patients with high levels of free copper, also known as Non-Cp Copper, are three times more likely to develop the kind of neurodegeneration associated with Alzheimer’s disease. This new elective laboratory test supplies a quantitative value of Non-Cp Copper in your blood stream.
The Danger of Non-Cp Copper
Excess Non-Cp Copper promotes the growth of Amyloid Beta peptides and Tau proteins in the brain that accelerate the progression of Alzheimer’s. Through changes in lifestyle and diet that you make now, you can prevent the onset or slow the progression of this devastating condition.
Take Charge of Your Future
With a prescription from a licensed physician, a free copper in serum test is performed using a fasting blood sample drawn at a laboratory or our state-of-the-art facility in Miami. IGEA Research Corporation developed the ALZ-1 Test to confront Alzheimer’s disease and empower patients to protect themselves from this tragic and costly disease.